Public Meeting About the Use of Naloxone to Reduce Opioid Drug Overdose Fatalities
View Registrations Tell a Friend About This EventTell a Friend

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research, in collaboration with the National Institute on Drug Abuse (NIDA), Substance Abuse and Mental Health Services Administration (SAMHSA) and HRSA held a public meeting to discuss increasing the use of naloxone to reduce the incidence of opioid drug overdose fatalities.

7/1/2015 to 7/2/2015
When: 7/1/2015
Where: Silver Spring, MD
« Go to Upcoming Event List  

Learn more about the public meeting here:  

Membership Software Powered by YourMembership  ::  Legal